A rizikófaktorok célértékei, kezelési kudarcok

Translated title of the contribution: Risk factor goals and therapeutic failures

András Káli, A. Jánosi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Risk factors' reduction decreases the number of vascular events. The therapy is successful, when target values of risk factors became realised. Aims: 3 modifiable risk factors - hyperlipidemia, hyperglycemia, hypertension - were checked in 350 high risk patients, comparing the target and the realised values of risk faktors. Methods: 1. Medical history of risk factors' therapy. 2. serum lipids and fasting blood glucose parameters. 3. Physical and ultrasound examinations for cerebro-, cardio- and peripheral vascular diseases, measurement of abdominal circumference and blood pressure. 4. Risk stratification. 5. Statistical analysis. Results: 1. Mean LDL-cholesterol was 3 ± 0.94 and 3.3 ± 0.87 in the group of patients with and without therapy, respectively (p <0.01). Number of not treated patients is high (47.3%). 2. There were significantly (p = 0.053) more treated patients above blood sugar goals (6,7 mmol/1), than in the group of untreated patients. Mean fasting blood glucose were 8.11 ± 3,036 and 7.25 ± 1.925 mmol/l in treated and not treated group of patients, respectively (p = NS). 3. There were significantly (p <0.00001) more hypertensive patients above therapeutic goal in the treated and less in the untreated group of patients. Mean tension (153,4 ± 22.42 and 139.7 ± 20.76) was significantly (p <0,001) higher in the treated, and lower in the untreated group of patients. 4. Number of risk factors are more in high risk patients. Only 5.2% of patients became free of risk factors by recent clinical practice and in 72.3% remained 2 or 3 factors. Conclusions: Most part of patients do not reach the therapeutic goals, and there are many persons without any therapy for hyperlipidaemia. To cure and to treat are different.

Original languageHungarian
Pages (from-to)65-70
Number of pages6
JournalOrvosi Hetilap
Volume147
Issue number2
Publication statusPublished - Jan 15 2006

Fingerprint

Therapeutics
Blood Glucose
Hyperlipidemias
Fasting
Peripheral Vascular Diseases
Risk Reduction Behavior
Hyperglycemia
LDL Cholesterol
Physical Examination
Blood Vessels
Blood Pressure
Hypertension
Lipids
Serum

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A rizikófaktorok célértékei, kezelési kudarcok. / Káli, András; Jánosi, A.

In: Orvosi Hetilap, Vol. 147, No. 2, 15.01.2006, p. 65-70.

Research output: Contribution to journalArticle

Káli, András ; Jánosi, A. / A rizikófaktorok célértékei, kezelési kudarcok. In: Orvosi Hetilap. 2006 ; Vol. 147, No. 2. pp. 65-70.
@article{f55947b3b19741c0bb12195aab2524fb,
title = "A rizik{\'o}faktorok c{\'e}l{\'e}rt{\'e}kei, kezel{\'e}si kudarcok",
abstract = "Risk factors' reduction decreases the number of vascular events. The therapy is successful, when target values of risk factors became realised. Aims: 3 modifiable risk factors - hyperlipidemia, hyperglycemia, hypertension - were checked in 350 high risk patients, comparing the target and the realised values of risk faktors. Methods: 1. Medical history of risk factors' therapy. 2. serum lipids and fasting blood glucose parameters. 3. Physical and ultrasound examinations for cerebro-, cardio- and peripheral vascular diseases, measurement of abdominal circumference and blood pressure. 4. Risk stratification. 5. Statistical analysis. Results: 1. Mean LDL-cholesterol was 3 ± 0.94 and 3.3 ± 0.87 in the group of patients with and without therapy, respectively (p <0.01). Number of not treated patients is high (47.3{\%}). 2. There were significantly (p = 0.053) more treated patients above blood sugar goals (6,7 mmol/1), than in the group of untreated patients. Mean fasting blood glucose were 8.11 ± 3,036 and 7.25 ± 1.925 mmol/l in treated and not treated group of patients, respectively (p = NS). 3. There were significantly (p <0.00001) more hypertensive patients above therapeutic goal in the treated and less in the untreated group of patients. Mean tension (153,4 ± 22.42 and 139.7 ± 20.76) was significantly (p <0,001) higher in the treated, and lower in the untreated group of patients. 4. Number of risk factors are more in high risk patients. Only 5.2{\%} of patients became free of risk factors by recent clinical practice and in 72.3{\%} remained 2 or 3 factors. Conclusions: Most part of patients do not reach the therapeutic goals, and there are many persons without any therapy for hyperlipidaemia. To cure and to treat are different.",
keywords = "Hyperglycemia, Hyperlipidemia, Hypertension, Risk factors",
author = "Andr{\'a}s K{\'a}li and A. J{\'a}nosi",
year = "2006",
month = "1",
day = "15",
language = "Hungarian",
volume = "147",
pages = "65--70",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "2",

}

TY - JOUR

T1 - A rizikófaktorok célértékei, kezelési kudarcok

AU - Káli, András

AU - Jánosi, A.

PY - 2006/1/15

Y1 - 2006/1/15

N2 - Risk factors' reduction decreases the number of vascular events. The therapy is successful, when target values of risk factors became realised. Aims: 3 modifiable risk factors - hyperlipidemia, hyperglycemia, hypertension - were checked in 350 high risk patients, comparing the target and the realised values of risk faktors. Methods: 1. Medical history of risk factors' therapy. 2. serum lipids and fasting blood glucose parameters. 3. Physical and ultrasound examinations for cerebro-, cardio- and peripheral vascular diseases, measurement of abdominal circumference and blood pressure. 4. Risk stratification. 5. Statistical analysis. Results: 1. Mean LDL-cholesterol was 3 ± 0.94 and 3.3 ± 0.87 in the group of patients with and without therapy, respectively (p <0.01). Number of not treated patients is high (47.3%). 2. There were significantly (p = 0.053) more treated patients above blood sugar goals (6,7 mmol/1), than in the group of untreated patients. Mean fasting blood glucose were 8.11 ± 3,036 and 7.25 ± 1.925 mmol/l in treated and not treated group of patients, respectively (p = NS). 3. There were significantly (p <0.00001) more hypertensive patients above therapeutic goal in the treated and less in the untreated group of patients. Mean tension (153,4 ± 22.42 and 139.7 ± 20.76) was significantly (p <0,001) higher in the treated, and lower in the untreated group of patients. 4. Number of risk factors are more in high risk patients. Only 5.2% of patients became free of risk factors by recent clinical practice and in 72.3% remained 2 or 3 factors. Conclusions: Most part of patients do not reach the therapeutic goals, and there are many persons without any therapy for hyperlipidaemia. To cure and to treat are different.

AB - Risk factors' reduction decreases the number of vascular events. The therapy is successful, when target values of risk factors became realised. Aims: 3 modifiable risk factors - hyperlipidemia, hyperglycemia, hypertension - were checked in 350 high risk patients, comparing the target and the realised values of risk faktors. Methods: 1. Medical history of risk factors' therapy. 2. serum lipids and fasting blood glucose parameters. 3. Physical and ultrasound examinations for cerebro-, cardio- and peripheral vascular diseases, measurement of abdominal circumference and blood pressure. 4. Risk stratification. 5. Statistical analysis. Results: 1. Mean LDL-cholesterol was 3 ± 0.94 and 3.3 ± 0.87 in the group of patients with and without therapy, respectively (p <0.01). Number of not treated patients is high (47.3%). 2. There were significantly (p = 0.053) more treated patients above blood sugar goals (6,7 mmol/1), than in the group of untreated patients. Mean fasting blood glucose were 8.11 ± 3,036 and 7.25 ± 1.925 mmol/l in treated and not treated group of patients, respectively (p = NS). 3. There were significantly (p <0.00001) more hypertensive patients above therapeutic goal in the treated and less in the untreated group of patients. Mean tension (153,4 ± 22.42 and 139.7 ± 20.76) was significantly (p <0,001) higher in the treated, and lower in the untreated group of patients. 4. Number of risk factors are more in high risk patients. Only 5.2% of patients became free of risk factors by recent clinical practice and in 72.3% remained 2 or 3 factors. Conclusions: Most part of patients do not reach the therapeutic goals, and there are many persons without any therapy for hyperlipidaemia. To cure and to treat are different.

KW - Hyperglycemia

KW - Hyperlipidemia

KW - Hypertension

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=33645519069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645519069&partnerID=8YFLogxK

M3 - Article

VL - 147

SP - 65

EP - 70

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 2

ER -